Kezar Life Sciences, Inc. - Common Stock (KZR)
CUSIP: 49372L209
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 7,437,095
- Total 13F shares
- 1,440,173
- Share change
- +1,421,873
- Total reported value
- $1,113,903
- Price per share
- $0.77
- Number of holders
- 3
- Value change
- +$1,099,753
- Number of buys
- 2
Quarterly Holders Quick Answers
What is CUSIP 49372L209?
CUSIP 49372L209 identifies KZR - Kezar Life Sciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 49372L209:
Top shareholders of KZR - Kezar Life Sciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
97%
|
7,167,591
|
$4,300,555 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
68%
|
5,026,000
|
$3,015,600 | — | 30 Jun 2024 | |
| Morningside Venture Investments Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,947,993
|
$1,753,194 | — | 15 Aug 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
37%
|
2,741,105
|
$1,644,663 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
28%
|
2,051,676
|
$1,231,006 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
26%
|
1,927,000
|
$1,156,200 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
25%
|
1,855,194
|
$1,112,000 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
24%
|
1,761,778
|
$1,057,067 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
17%
|
1,237,600
|
$742,560 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
16%
|
1,148,181
|
$688,909 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
15%
|
1,086,498
|
$651,899 | — | 30 Jun 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
14%
|
1,050,452
|
$630,271 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
14%
|
1,019,176
|
$611,505 | — | 30 Jun 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
13%
|
986,785
|
$592,071 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
12%
|
868,992
|
$521,395 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
11%
|
830,371
|
$498,222 | — | 30 Jun 2024 | |
| Qiming U.S. Ventures Management, LLC |
13F
|
Company |
11%
|
828,711
|
$497,227 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
11%
|
778,474
|
$467,084 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
8.5%
|
628,514
|
$377,108 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
7.4%
|
549,062
|
$329,437 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
7.4%
|
545,234
|
$327,226 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
6.5%
|
483,187
|
$289,912 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
6.1%
|
449,778
|
$269,867 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
6%
|
443,724
|
$266,234 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
4.7%
|
350,394
|
$210,236 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
3.9%
|
289,719
|
$173,831 | — | 30 Jun 2024 | |
| RBF Capital, LLC |
13F
|
Company |
3.8%
|
282,521
|
$169,513 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
3.8%
|
279,265
|
$167,559 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.3%
|
246,841
|
$148,104 | — | 30 Jun 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
3.1%
|
227,701
|
$136,621 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
185,941
|
$111,565 | — | 30 Jun 2024 | |
| Marquette Asset Management, LLC |
13F
|
Company |
2.4%
|
178,056
|
$106,834 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2.1%
|
156,584
|
$93,950 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
2%
|
150,485
|
$90,291 | — | 30 Jun 2024 | |
| Centiva Capital, LP |
13F
|
Company |
2%
|
147,800
|
$88,680 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
108,600
|
$65,160 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
105,389
|
$63,233 | — | 30 Jun 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
1.4%
|
105,105
|
$63,063 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
83,600
|
$51,000 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.1%
|
79,512
|
$47,707 | — | 30 Jun 2024 | |
| Amundi |
13F
|
Individual |
1.1%
|
82,243
|
$47,627 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
1.1%
|
77,736
|
$46,000 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.86%
|
63,358
|
$38,015 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.84%
|
62,288
|
$37,373 | — | 30 Jun 2024 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.79%
|
58,709
|
$35,225 | — | 30 Jun 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.76%
|
56,080
|
$33,648 | — | 30 Jun 2024 | |
| Paloma Partners Management Co |
13F
|
Company |
0.76%
|
56,059
|
$33,635 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.6%
|
44,400
|
$26,640 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.55%
|
40,837
|
$24,502 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.48%
|
35,794
|
$21,476 | — | 30 Jun 2024 |
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock (KZR) as of Q3 2024
As of 30 Sep 2024,
Kezar Life Sciences, Inc. - Common Stock (KZR) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,440,173 shares.
The largest 3 holders included
ADAR1 Capital Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Catalyst Funds Management Pty Ltd.
This page lists
3
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
1
Q3 2024 holders
3
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.